1 Min Read
Sept 28 (Reuters) - Theratechnologies Inc
* Theratechnologies to move forward with development of new single vial formulation for EGRIFTA(R)(Tesamorelin for injection) Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.